Initiativbewerbung als Techniker (m/w/d) at Acadia Pharmaceuticals

Kiel, Schleswig-Holstein, Germany

Acadia Pharmaceuticals Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

  • Completed training as Industrieelektroniker (m/w/d) specializing in Automation
  • Completed training as Industrieelektroniker (m/w/d) specializing in Devices & Systems
  • Completed training as Mechatroniker (m/w/d)
  • Completed training as Industriemechaniker (m/w/d)
  • Ideally, additional qualification as "Elektrofachkraft"
  • Good understanding of process flows, e.g., maintaining process technology of installed production plants, ensuring high technical plant availability, and maintaining operational capability and reliability of process plants
  • Precise and conscientious work ethic, e.g., maintaining GMP-compliant state of manufacturing processes and equipment, as well as troubleshooting, fault elimination, and repair work on production machines and plants
  • Willingness for flexible working hours, possibly including shift work and weekend work
  • Willingness for on-call duty (Rufbereitschaft) outside normal working hours

Responsibilities

  • Creation and maintenance of related documentation, such as plant documentation, logbooks, maintenance plans, maintenance protocols, operating instructions, spare parts lists, etc
  • Maintenance and upkeep of spare parts and the spare parts warehouse
  • Performing and assisting with tool changes and format adjustments on filling machines and process plants
  • Independent maintenance of process equipment according to specifications
  • Participation in the setup and commissioning of new plants

Skills

GMP
Automation
Mechatronics
Industrial Mechanics
Electrical Technician
Process Maintenance
Troubleshooting
Equipment Repair
Preventive Maintenance
Documentation
Spare Parts Management
Equipment Commissioning

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI